FDA
approval
· 2025-07-07
FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
The FDA approved Camber Pharmaceuticals' Eletriptan Hydrobromide as an original generic application for the acute treatment of migraine in adults.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)